TOPIC
2024REPORTING News & Analysis
Stocks
Impressive full year results lifted the neobank's valuation even higher. The rally may be overdone.
Joseph Taylor | 22 August 2024
Stocks
Investors cheer the latest results as the distribution is lifted 6%.
Brian Han | 21 August 2024
Stocks
An enviable brand but supplier problems have derailed the shares which remain undervalued.
Joseph Taylor | 20 August 2024
Stocks
We reaffirm our full year guidance and the firm remains undervalued.
Jon Mills | 19 August 2024
Stocks
Our view after the shares have appreciated over 42% in the last year.
Nathan Zaia | 19 August 2024
Stocks
We heard from some of the heavy weights in the ASX 200 including CBA and CSL.
Morningstar | 18 August 2024
Stocks
We leave our fair value unchanged but the shares are trading at a 11% discount.
Esther Holloway | 18 August 2024
Stocks
Our analysts disagree with how the market is valuing these ASX companies. Next week’s earnings reports could offer some clues as to whether we...
Joseph Taylor | 17 August 2024
Stocks
Has the share price run too far or is there room for further gains?
Nathan Zaia | 15 August 2024
Stocks
Pro Medicus reported another strong set of results. It continues to trade at a lofty valuation.
Joseph Taylor | 15 August 2024
of 2
Viewing 1 to 10 of 16